Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

January 16, 2021
Review
Open Access

Correlation of genomic alterations and PD-L1 expression in thymoma

Journal of Thoracic Disease
Dragana JovanovicIvan Soldatovic
January 15, 2021
Preprint
Open Access

Somatic Genomic Defects And Tumor Progression In NF1-associated Tumors

ResearchSquare
Yah-Huei Wu-ChouYu-Ray Chen
January 17, 2021

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers

Journal of Medical Genetics
D Gareth EvansEmma J Crosbie
January 17, 2021

Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Catherine H MarshallEmmanuel S Antonarakis
January 15, 2021
Preprint
Open Access

Reshaping the Gut Microbiome in An Apc-Mutant Genetic Background: Mechanistic Insights From Integrated Multi-Omics

ResearchSquare
Ying-Shiuan ChenRoderick Dashwood
January 15, 2021
Review
Open Access

Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation

Cancers
Francesca BenedettiDavide Zella
January 16, 2021

The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Zhiyuan HuAhmed Ahmed
January 16, 2021
Review

Small-cell lung cancer

Nature Reviews. Disease Primers
Charles M RudinJulien Sage
January 15, 2021
Open Access

Fission Yeast Methylenetetrahydrofolate Reductase Ensures Mitotic and Meiotic Chromosome Segregation Fidelity

International Journal of Molecular Sciences
Kim Kiat LimEe Sin Chen
January 16, 2021
Review

Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides

Trends in Cancer
Ilio VitaleLorenzo Galluzzi
January 17, 2021

A bispecific single domain antibody boosts autologous Vγ9Vδ2-T cell responses towards CD1d in chronic lymphocytic leukemia

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Iris de WeerdtHans J van der Vliet
January 15, 2021
Open Access

Targetable alterations in invasive pleomorphic lobular carcinoma of the breast

Breast Cancer Research : BCR
Gregory M RiedlingerShridar Ganesan
January 17, 2021
Open Access

Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS

Molecular & Cellular Proteomics : MCP
Samvel K GularyanMarat S Pavlyukov
January 17, 2021
Review
Open Access

The Biological Roles of lncRNAs and Future Prospects in Clinical Application

Diseases
Guohui LiFenyong Sun
January 16, 2021
Review

Circulating tumor cell profiling for precision oncology

Molecular Oncology
Mahmoud Labib, Shana O Kelley
January 15, 2021
Preprint
Open Access

Spatiotemporal transcriptional dynamics of the cycling mouse oviduct

BioRxiv : the Preprint Server for Biology
E. RobersonJohn Wallingford
January 16, 2021

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines

Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
Jordan AyersMarc Salute

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2021 Meta ULC. All rights reserved
/feed-previews/cancer-genomics-keystone/f928f68c-ddb8-4875-a183-4d03bc545fde